Cargando…

Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using (111)In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements

Progressive loss of β-cell mass (BCM) has a pernicious influence on type 2 diabetes mellitus (T2DM); evaluation of BCM has conventionally required an invasive method that provides only cross-sectional data. However, a noninvasive approach to longitudinal assessment of BCM in living subjects using an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fauzi, Muhammad, Murakami, Takaaki, Fujimoto, Hiroyuki, Botagarova, Ainur, Sakaki, Kentaro, Kiyobayashi, Sakura, Ogura, Masahito, Inagaki, Nobuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559817/ https://www.ncbi.nlm.nih.gov/pubmed/36246910 http://dx.doi.org/10.3389/fendo.2022.1010825

Ejemplares similares

Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with (111)In-labeled exendin-4
por: Hamamatsu, Keita, et al.
Publicado: (2019)

(18)F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma
por: Sakaki, Kentaro, et al.
Publicado: (2023)

Current understanding of imeglimin action on pancreatic β‐cells: Involvement of mitochondria and endoplasmic reticulum homeostasis
por: Fauzi, Muhammad, et al.
Publicado: (2022)

Noninvasive evaluation of donor and native pancreases following simultaneous pancreas–kidney transplantation using positron emission tomography/computed tomography
por: Murakami, Takaaki, et al.
Publicado: (2023)

Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet
por: Kiyobayashi, Sakura, et al.
Publicado: (2022)

Generation and Characterization of a Novel Mouse Model That Allows Spatiotemporal Quantification of Pancreatic β-Cell Proliferation
por: Tokumoto, Shinsuke, et al.
Publicado: (2020)

Voxel‐based specific regional analysis system for Alzheimer’s disease utility as a screening tool for unrecognized cognitive dysfunction of elderly patients in diabetes outpatient clinics: Multicenter retrospective exploratory study
por: Ueba, Yoko, et al.
Publicado: (2021)

Distinctive detection of insulinoma using [(18)F]FB(ePEG12)12-exendin-4 PET/CT
por: Murakami, Takaaki, et al.
Publicado: (2021)

GPR40 activation initiates store-operated Ca(2+) entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells
por: Usui, Ryota, et al.
Publicado: (2019)

Single-Cell Transcriptome Analysis Dissects the Replicating Process of Pancreatic Beta Cells in Partial Pancreatectomy Model
por: Tatsuoka, Hisato, et al.
Publicado: (2020)

Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond
por: Murakami, Takaaki, et al.
Publicado: (2021)

A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using (111)In-exendin
por: Woliner-van der Weg, Wietske, et al.
Publicado: (2016)

Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
por: Yasuda, Takuma, et al.
Publicado: (2021)

Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
por: Tsukaguchi, Ryo, et al.
Publicado: (2022)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

Stimulatory effect of imeglimin on incretin secretion
por: Yingyue, Quan, et al.
Publicado: (2023)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3
por: Eter, Wael A., et al.
Publicado: (2017)

Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects
por: Fouqueray, Pascale, et al.
Publicado: (2022)

Development of (111)In-labeled porphyrins for SPECT imaging
por: Sadeghi, Shaghayegh, et al.
Publicado: (2014)

Exendin-4 Suppresses Src Activation and Reactive Oxygen Species Production in Diabetic Goto-Kakizaki Rat Islets in an Epac-Dependent Manner
por: Mukai, Eri, et al.
Publicado: (2011)

Absence of GIP secretion alleviates age-related obesity and insulin resistance
por: Kanemaru, Yoshinori, et al.
Publicado: (2020)

First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [(18)F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
por: Fujimoto, Hiroyuki, et al.
Publicado: (2021)

Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin
por: Theurey, Pierre, et al.
Publicado: (2022)

Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF rats
por: Hallakou‐Bozec, Sophie, et al.
Publicado: (2020)

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
por: Himeno, Tatsuhito, et al.
Publicado: (2011)

Noninvasive Measurement of Gastric Accommodation by SPECT
por: Kim, Doe Young, et al.
Publicado: (2002)

Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma
por: Murakami, Takaaki, et al.
Publicado: (2017)

Medium-chain triglycerides inhibit long-chain triglyceride-induced GIP secretion through GPR120-dependent inhibition of CCK
por: Murata, Yuki, et al.
Publicado: (2021)

Effects of the anti-diabetic imeglimin in hyperglycemic mice with septic shock
por: Wagner, F, et al.
Publicado: (2012)

The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells
por: Vial, Guillaume, et al.
Publicado: (2021)

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023)

Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling
por: Takeuchi, Masato, et al.
Publicado: (2022)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020)

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology
por: Murakami, Takaaki, et al.
Publicado: (2019)

Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan
por: Murakami, Takaaki, et al.
Publicado: (2021)

Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells
por: Murakami, Takaaki, et al.
Publicado: (2022)

Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
por: Hozumi, Kaori, et al.
Publicado: (2023)

Palmitate induces reactive oxygen species production and β‐cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling
por: Sato, Yuichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ttqrjgq6crp4eoems8kcsk0kr